$157 Million is the total value of HighVista Strategies LLC's 86 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 88.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DELL | DELL TECHNOLOGIES INCcl c | $17,840,000 | -10.6% | 355,444 | 0.0% | 11.34% | -28.6% | |
| V | New | VISA INC | $9,122,000 | – | 41,135 | +100.0% | 5.80% | – |
| MA | New | MASTERCARD INCORPORATEDcl a | $8,650,000 | – | 24,204 | +100.0% | 5.50% | – |
| FISV | New | FISERV INC | $8,445,000 | – | 83,286 | +100.0% | 5.37% | – |
| PYPL | New | PAYPAL HLDGS INC | $5,865,000 | – | 50,718 | +100.0% | 3.73% | – |
| MSDAU | MSD ACQUISITION CORPunit 03/25/2026 | $4,940,000 | -2.8% | 500,000 | 0.0% | 3.14% | -22.3% | |
| CPNG | COUPANG INCcl a | $4,531,000 | -39.8% | 256,264 | 0.0% | 2.88% | -51.9% | |
| PBCT | PEOPLES UNITED FINANCIAL INC | $3,920,000 | +12.2% | 196,100 | 0.0% | 2.49% | -10.4% | |
| FIS | New | FIDELITY NATL INFORMATION SV | $3,846,000 | – | 38,303 | +100.0% | 2.44% | – |
| COHR | COHERENT INC | $3,717,000 | +2.5% | 13,600 | 0.0% | 2.36% | -18.1% | |
| CHNG | CHANGE HEALTHCARE INC | $3,534,000 | +2.0% | 162,100 | 0.0% | 2.25% | -18.6% | |
| CERN | New | CERNER CORP | $3,490,000 | – | 37,300 | +100.0% | 2.22% | – |
| ATVI | New | ACTIVISION BLIZZARD INC | $3,204,000 | – | 40,000 | +100.0% | 2.04% | – |
| FHN | New | FIRST HORIZON CORPORATION | $3,181,000 | – | 135,400 | +100.0% | 2.02% | – |
| CTXS | New | CITRIX SYS INC | $3,169,000 | – | 31,400 | +100.0% | 2.02% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $2,728,000 | +67.3% | 158,243 | +41.1% | 1.73% | +33.6% |
| FATE | Buy | FATE THERAPEUTICS INC | $2,507,000 | +85.7% | 64,665 | +180.2% | 1.59% | +48.3% |
| CYTK | Buy | CYTOKINETICS INC | $2,421,000 | +50.7% | 65,769 | +86.7% | 1.54% | +20.3% |
| KURA | Buy | KURA ONCOLOGY INC | $2,377,000 | +106.7% | 147,833 | +80.0% | 1.51% | +65.0% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $2,180,000 | +105.7% | 92,045 | +196.9% | 1.39% | +64.2% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $2,053,000 | +45.4% | 68,608 | +49.2% | 1.30% | +16.1% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $2,042,000 | +122.7% | 143,375 | +229.6% | 1.30% | +77.8% |
| CPARU | CATALYST PARTNRS ACQUISITN Cunit 99/99/9999 | $2,020,000 | +0.9% | 200,000 | 0.0% | 1.28% | -19.4% | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $1,875,000 | – | 36,893 | +100.0% | 1.19% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $1,770,000 | – | 51,085 | +100.0% | 1.12% | – |
| DYN | New | DYNE THERAPEUTICS INC | $1,626,000 | – | 168,691 | +100.0% | 1.03% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $1,580,000 | – | 50,050 | +100.0% | 1.00% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $1,568,000 | – | 476,744 | +100.0% | 1.00% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,503,000 | – | 12,678 | +100.0% | 0.96% | – |
| NVCR | New | NOVOCURE LTD | $1,446,000 | – | 17,448 | +100.0% | 0.92% | – |
| KDNY | New | CHINOOK THERAPEUTICS INC | $1,109,000 | – | 67,777 | +100.0% | 0.70% | – |
| DBC | INVESCO DB COMMDY INDX TRCKunit | $1,105,000 | +25.4% | 42,396 | 0.0% | 0.70% | +0.3% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $1,025,000 | -21.8% | 108,257 | -4.5% | 0.65% | -37.5% |
| RNA | Buy | AVIDITY BIOSCIENCES INC | $982,000 | -6.7% | 53,164 | +20.0% | 0.62% | -25.5% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $979,000 | -13.2% | 3,752 | -26.9% | 0.62% | -30.7% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $971,000 | -35.5% | 44,226 | -16.5% | 0.62% | -48.5% |
| ARGX | Sell | ARGENX SEsponsored adr | $965,000 | -50.5% | 3,061 | -45.0% | 0.61% | -60.4% |
| GHRS | Buy | GH RESEARCH PLCordinary shares | $966,000 | +53.3% | 52,840 | +95.6% | 0.61% | +22.3% |
| GBIO | New | GENERATION BIO CO | $964,000 | – | 131,295 | +100.0% | 0.61% | – |
| New | DICE THERAPEUTICS INC | $937,000 | – | 48,960 | +100.0% | 0.60% | – | |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $918,000 | -20.1% | 7,821 | -8.4% | 0.58% | -36.2% |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $907,000 | – | 49,065 | +100.0% | 0.58% | – |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $907,000 | -24.6% | 5,555 | -21.7% | 0.58% | -39.8% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $906,000 | -28.8% | 54,401 | -18.4% | 0.58% | -43.1% |
| ISEE | Sell | IVERIC BIO INC | $902,000 | -46.7% | 53,583 | -47.0% | 0.57% | -57.4% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $884,000 | – | 11,310 | +100.0% | 0.56% | – |
| TCDA | New | TRICIDA INC | $881,000 | – | 107,202 | +100.0% | 0.56% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $877,000 | -24.0% | 25,738 | -13.8% | 0.56% | -39.3% |
| KROS | New | KEROS THERAPEUTICS INC | $872,000 | – | 16,040 | +100.0% | 0.55% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $869,000 | -28.6% | 8,256 | -26.9% | 0.55% | -43.0% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $866,000 | +53.3% | 85,300 | +152.0% | 0.55% | +22.4% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $856,000 | -56.4% | 27,992 | -55.5% | 0.54% | -65.2% |
| CCCC | Buy | C4 THERAPEUTICS INC | $843,000 | -16.9% | 34,760 | +10.4% | 0.54% | -33.6% |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $838,000 | -50.1% | 32,501 | -39.9% | 0.53% | -60.1% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $826,000 | – | 34,116 | +100.0% | 0.52% | – |
| GLPG | New | GALAPAGOS NVspon adr | $819,000 | – | 13,209 | +100.0% | 0.52% | – |
| MRUS | Sell | MERUS N V | $803,000 | -53.1% | 30,388 | -43.6% | 0.51% | -62.5% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $803,000 | – | 18,298 | +100.0% | 0.51% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $802,000 | -40.8% | 9,753 | +5.6% | 0.51% | -52.7% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $764,000 | -25.4% | 48,191 | +2.7% | 0.49% | -40.4% |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $734,000 | -54.3% | 22,812 | -33.9% | 0.47% | -63.5% |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $705,000 | – | 46,243 | +100.0% | 0.45% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $645,000 | – | 207,307 | +100.0% | 0.41% | – |
| BEAM | Sell | BEAM THERAPEUTICS INC | $636,000 | -41.1% | 11,102 | -18.0% | 0.40% | -53.0% |
| GOSS | New | GOSSAMER BIO INC | $608,000 | – | 70,042 | +100.0% | 0.39% | – |
| NVTA | Buy | INVITAE CORP | $602,000 | -12.4% | 75,472 | +67.8% | 0.38% | -30.0% |
| EWTX | New | EDGEWISE THERAPEUTICS INC | $579,000 | – | 59,733 | +100.0% | 0.37% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $577,000 | – | 21,381 | +100.0% | 0.37% | – |
| TPTX | New | TURNING POINT THERAPEUTICS I | $565,000 | – | 21,037 | +100.0% | 0.36% | – |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $554,000 | -42.3% | 49,527 | +21.9% | 0.35% | -53.9% |
| NTRA | Buy | NATERA INC | $547,000 | -46.9% | 13,448 | +21.8% | 0.35% | -57.6% |
| BMEA | New | BIOMEA FUSION INC | $504,000 | – | 112,918 | +100.0% | 0.32% | – |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $477,000 | -64.8% | 2,657 | -57.6% | 0.30% | -71.9% |
| PRTA | Sell | PROTHENA CORP PLC | $474,000 | -65.8% | 12,953 | -53.9% | 0.30% | -72.7% |
| BLU | New | BELLUS HEALTH INC NEW | $448,000 | – | 65,174 | +100.0% | 0.28% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $444,000 | – | 4,525 | +100.0% | 0.28% | – |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $438,000 | -60.5% | 7,755 | -56.6% | 0.28% | -68.5% |
| MORF | Sell | MORPHIC HLDG INC | $438,000 | -61.1% | 10,917 | -54.0% | 0.28% | -69.0% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $431,000 | – | 5,593 | +100.0% | 0.27% | – |
| IMAB | New | I MABsponsored ads | $413,000 | – | 25,402 | +100.0% | 0.26% | – |
| VTGN | Sell | VISTAGEN THERAPEUTICS INC | $392,000 | -65.2% | 315,880 | -45.3% | 0.25% | -72.2% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $378,000 | -45.9% | 2,002 | -22.4% | 0.24% | -56.8% |
| IMGN | New | IMMUNOGEN INC | $370,000 | – | 77,694 | +100.0% | 0.24% | – |
| GRTS | Sell | GRITSTONE BIO INC | $364,000 | -75.1% | 88,318 | -22.4% | 0.23% | -80.2% |
| ANAB | New | ANAPTYSBIO INC | $346,000 | – | 13,998 | +100.0% | 0.22% | – |
| VERV | Sell | VERVE THERAPEUTICS INC | $321,000 | -53.6% | 14,073 | -25.1% | 0.20% | -63.0% |
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -22,434 | -100.0% | -0.12% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -20,659 | -100.0% | -0.15% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -58,965 | -100.0% | -0.33% | – |
| Exit | ADAGIO THERAPEUTICS INC | $0 | – | -65,068 | -100.0% | -0.38% | – | |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -50,942 | -100.0% | -0.38% | – |
| NRIX | Exit | NURIX THERAPEUTICS INC | $0 | – | -18,796 | -100.0% | -0.43% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -40,612 | -100.0% | -0.46% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -89,220 | -100.0% | -0.60% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -46,264 | -100.0% | -0.65% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -38,347 | -100.0% | -0.67% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -54,012 | -100.0% | -0.69% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -39,777 | -100.0% | -0.73% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -56,901 | -100.0% | -0.78% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -29,753 | -100.0% | -0.78% | – |
| Exit | AADI BIOSCIENCE INC | $0 | – | -40,549 | -100.0% | -0.78% | – | |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -13,843 | -100.0% | -1.18% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -89,963 | -100.0% | -1.27% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -21,433 | -100.0% | -1.59% | – |
| CONE | Exit | CYRUSONE INC | $0 | – | -38,700 | -100.0% | -2.76% | – |
| NUAN | Exit | NUANCE COMMUNICATIONS INC | $0 | – | -64,841 | -100.0% | -2.86% | – |
| INFO | Exit | IHS MARKIT LTD | $0 | – | -32,743 | -100.0% | -3.46% | – |
| XLNX | Exit | XILINX INC | $0 | – | -24,173 | -100.0% | -4.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 29 | Q2 2023 | 2.9% |
| VANGUARD INDEX FDS | 24 | Q4 2019 | 26.4% |
| APPLE INC | 24 | Q4 2019 | 2.0% |
| ISHARES TR | 22 | Q3 2018 | 7.9% |
| MICROSOFT CORP | 21 | Q3 2023 | 2.0% |
| VISA INC | 20 | Q3 2023 | 5.8% |
| INVESCO DB COMMDY INDX TRCK | 20 | Q3 2023 | 16.6% |
| VERIZON COMMUNICATIONS INC | 20 | Q4 2019 | 0.4% |
| ALIBABA GROUP HLDG LTD | 19 | Q3 2023 | 7.7% |
| AMAZON COM INC | 19 | Q3 2023 | 2.9% |
View HighVista Strategies LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STG Group, Inc.Sold out | February 16, 2016 | 0 | 0.0% |
| SAExploration Holdings, Inc. | February 12, 2014 | 25,000 | 0.2% |
| Trio Merger Corp. | February 14, 2013 | 690,000 | 8.8% |
View HighVista Strategies LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View HighVista Strategies LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.